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The first case of spongiform encephalopathy in a zebu
(Bos indicus) was identified in a zoo in Switzerland.
Although histopathologic and immunohistochemical analy-
ses of the central nervous system indicated a diagnosis of
bovine spongiform encephalopathy (BSE), molecular typ-
ing showed some features different from those of BSE in
cattle (B. taurus).
Spongiform encephalopathies (SEs) are transmissibleneurodegenerative diseases characterized by spongi-
form lesions and deposition of partially proteinase
K–resistant prion protein (PrPsc), a misfolded isoform of
the normal host-encoded cellular prion protein (PrPc), in
the central nervous system (CNS). The oldest known SE is
scrapie, which occurs naturally in sheep and goats. Since
the onset of the bovine spongiform encephalopathy (BSE)
epidemic in British cattle (Bos taurus) in 1986, novel SEs
emerged in other animal species including domestic cats
(1), a goat (2), primates (3), and several members of the
families Bovidae and Felidae in zoos (4,5). Experimental
and epidemiologic evidence indicate that these animals
were infected by ingesting BSE-infected carcasses or meat
and bone meal.
Zebus (B. indicus) belong to the family Bovidae. In
Asia they are raised mainly as productive livestock, but in
Europe they live primarily in zoos. We describe clinical,
pathologic, and molecular features of the first case of SE
in a zebu and address the question whether this animal was
infected with the BSE agent.
The Study
In 2004, a 19-year-old miniature zebu in a zoo in Basel,
Switzerland, fell during mating, after which it had abnor-
mal gait and posture. After 6 weeks it started to bump into
obstacles and showed anxiety and loss of proprioceptive
control. Because of its old age and the progressive course
of the disease, the animal was euthanized, and multiple
organs were examined postmortem (Table 1).
Histopathologic examination showed severe spongiform
changes and a moderate gliosis in the brainstem (Figure
1A, nucleus of the solitary tract), and many other CNS
structures. Immunohistochemical analysis (6), which used
the monoclonal antibodies (MAbs) F99/97.6.1 (VMRD,
Pullman, WA, USA) and P4 (R-biopharm, Darmstadt,
Germany), identified a marked deposition of PrPsc in the
neuropil (granular type) and the neurons (Figure 1B and
1C). The cerebral cortex contained a moderately increased
number of Alzheimer type II cells. Numerous nonnervous
tissues, including the lymphoreticular system (Figure 1H),
were analyzed by immunohistochemical techniques for the
presence of PrPsc, but none was found. Taken together,
these findings led to the diagnosis of a severe SE in com-
bination with a mild metabolic encephalopathy.
To assess the possibility that this animal was infected
with the BSE agent, we compared the distribution of the
SE-related histopathologic lesions and the PrPsc deposits in
different brain structures of the zebu to those in the brain
of a Swiss BSE-affected cow. In both animals, spongiform
lesions were similarly distributed throughout the brain, but
overall the lesions in the zebu were more severe than those
in the cow (Table 2). The depositions of PrPsc in these
structures, as determined by immunohistochemical analy-
sis with MAb F99/97.6.1 and different commercial BSE
screening tests (Check Western, Prionics, Zurich,
Switzerland; TeSeE, Bio-Rad, Marnes-la-Coquette,
France), were well associated with the histopathologic
lesions in both animals (data not shown). In comparative
Western immunoblot (WB) analysis that used MAb 6H4
(Prionics), the zebu CNS samples (Figure 2, lanes 3 and 5)
showed a characteristic 3-band pattern representing un-,
mono- and diglycosylated moieties of the proteinase
K–resistant PrPsc fragment. In the zebu these 3 bands clear-
ly showed a migration pattern at a higher molecular mass
than that of BSE in the cow (Figure 2, lanes 4 and 6) but
similar to a sample from a sheep with scrapie (Figure 2,
lane 7). When samples of the same animals were analyzed
by WB (Figure 2) and immunohistochemical analysis
(Figure 1C–E) with P4, an MAb used to discriminate
between BSE and scrapie in sheep (7), PrPsc was detectable
in samples from the sheep with scrapie and the zebu under
investigation but not in the cow with BSE. Sequencing of
the open reading frame of the Prnp gene of the zebu con-
firmed that the encoded PrP protein was identical to the
B. taurus PrP amino acid sequence (as translated from
GenBank accession no. AJ298878).
Conclusions
In 1990, the first case of BSE in cattle in Switzerland
was diagnosed; since then, authorities have banned meat
and bone meal in ruminant feed in Switzerland. The zebu
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was born in 1985 and until 1990 ate commercial pellets
containing meat and bone meal. Consequently, it might
have been exposed to the BSE agent at <5 years of age.
The clinical signs of the zebu were specific for an SE
but could have been explained partially by other patholog-
ic findings, e.g., the degenerative lesions of the spine and
the metabolic encephalopathy (Table 1). However, promi-
nent spongiform changes and marked depositions of PrPsc
in the brain confirmed the clinical suspicion of an SE. The
distribution and type of the lesions (Table 2) and PrPsc
deposits in the brain of the zebu were very similar to those
in the brain of the Swiss BSE-affected cow and to findings
that have been described previously for BSE in cattle in
Switzerland (8,9) and elsewhere (10–12).
In contrast, molecular analysis of PrPsc clearly showed
a difference between the zebu and the BSE cow regarding
1) the apparent molecular mass of the PK-resistant frag-
ment of PrPsc on WB analysis and 2) the immunoreactivi-
ty with MAb P4 on WB and immunohistochemical
analyses. Both observations can be explained by extended
proteinase K cleavage at the N terminus of PrPsc in cattle
compared with the zebu, resulting in removal of the P4
epitope (7). Recently, very similar molecular findings were
reported from France (13) in 3 exceptionally old (8, 10,
and 11 years) cattle. These animals had an atypical PrPsc
WB profile, different from that traditionally seen in cattle
with BSE but indistinguishable from those in sheep with
natural scrapie and cattle with experimental scrapie. This
molecular phenotype was retained after transmission of the
disease to C57BL/6 mice (14). The authors speculated that
their findings may reflect either an infection with another
type of infectious agent distinct from BSE, e.g., scrapie, or
a sporadic form of SE in cattle. For the zebu, the latter
hypothesis is supported by the observation that the molec-
ular features of PrPsc were similar to the ones observed in
type 1 sporadic Creutzfeldt-Jakob disease (15), an SE in
humans. On the other hand, consistent with the findings on
WB, MAb P4 readily detected PrPsc by immunohistochem-
ical analyses of the CNS of the zebu and in sheep with
scrapie but not in bovine BSE under the conditions used.
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Figure 1. Histopathologic and immunohistochemical analyses. A) Spongiform lesions. B) Partially proteinase K–resistant prion protein
(PrPSC) deposits detected by immunohistochemistry (monoclonal antibody [MAb] F99/97.6.1 diluted 1:500) in the nucleus of the solitary
tract (STN) in the zebu under investigation. C–E) Comparative immunohistochemistry with MAb P4 (1:800) in the olivary nuclei of the
zebu (C), a bovine spongiform encephalopathy (BSE)-positive cow (D), and a scrapie-positive sheep (E). Insets show control tissue
slides of BSE-negative cattle. F–H) Immunohistochemistry for PrPSC in lymphoid tissue of the zebu (H, mediastinal lymph node), and a
BSE-negative cow (G, mandibular lymph node) with MAb L42 (R-biopharm, 1:800). A retropharyngeal lymph node of a scrapie-affected
sheep (F) and a brainstem tissue slide of the zebu (F, inset) served as positive controls. Pretreatment of the tissue slides comprised a
proteinase K–digestion step (5  g/mL, 15 min, 37°C).
Extracellular and intracellular PrPsc was detected by MAb
P4 in the zebu and the sheep with scrapie. By contrast, in
BSE-affected sheep, PrPsc was detected by MAb P4 in
extracellular but not intracellular space (16). However, fur-
ther investigations that use comparative pathology and
biologic strain typing would be required to characterize the
phenotype of SE in this zebu and the infectious agent in
more detail.
Whatever the origin of the disease, this case indicates
that zebus are not naturally resistant to SE and, therefore,
that B. indicus should be included in programs that moni-
tor transmissible spongiform encephalopathies (TSEs) and
in risk assessments in countries where these animals are
part of the domestic livestock. Although the potential for
this disease to cross the species barrier to other animals
and humans is not known, zoos and veterinary services
should be aware of the possibility of SEs in such animals
so they can subsequently minimize the risk for foodborne
SE infections in other animal species (especially Felidae)
and humans by removing specified risk materials.
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